Membre de la ligne de métiers Banque-Finance, Melinda Stege Arsouze est une associée de droit américain spécialisée en marchés de capitaux.

Elle travaille en étroite collaboration avec les équipes Capital Markets de Gide dans le monde, avec une expérience approfondie pour les opérations en Europe, ainsi qu'au sein de la zone EMEA, en particulier en Turquie, en Afrique du Nord et en Asie.

Melinda conseille régulièrement des établissements financiers et des entreprises françaises dans le cadre de leurs opérations d'émission de titres de dette, ainsi que dans le cadre d'opérations de liability management. Elle a notamment une longue expérience avec des émissions de titres de dette par des grandes groupes françaises ayant des placements aux Etats-Unis sous la réglementation "144A".

Avant de rejoindre l'équipe Marchés de capitaux de Gide, Melinda a travaillé au sein de l'équipe Marchés de capitaux internationaux d'un cabinet new yorkais de tout premier plan.

Melinda Arsouze est référencée parmi les meilleurs experts en marchés de capitaux par les guides juridiques internationaux Chambers, Legal 500 et IFLR1000.

« Melinda Arsouze enters the rankings this year on the back of positive market feedback. She is experienced advising on international equity capital markets transactions, including IPOs and capital increases. She is dual-qualified in France and the USA. Strengths: "She always has very wise judgement." »
Chambers Europe & Global 2023 - Capital Market : Equity

« Gide Loyrette Nouel combines life sciences and technology-sector expertise with extensive experience handling IPOs, share capital increases and convertible bonds. It attracts high-profile public and private sector clients, including financial institutions and major corporations. Headed by Arnaud Duhamel and Melinda Stege Arsouze, the group also has capabilities in French and US law. Duhamel advised Morgan Stanley as joint global co-ordinator alongside Goldman Sachs on the global offering of ordinary shares in DBV Technologies, including a public offering of ordinary shares in the form of American Depositary Shares in the US and a private placement of ordinary shares in Europe. A recent highlight in the life sciences sector saw Stege Arsouze act for GenSight Biologics in a €22.5m global Regulation S private placement and in a Rule 144A private placement. Other clients include Inventiva, Société Générale and the Agence des participations de l'État. »
Legal 500 EMEA 2019

« Gide Loyrette Nouel has a core focus on French issuer IPOs, but also has in-depth knowledge of US instruments, including Nasdaq listings, Regulation S and 144A transactions. Arnaud Duhamel is the key adviser and cross-border specialist Melinda Stege Arsouze is particularly active in private placements in the US. »
Legal 500 EMEA 2018

« Clients highlight Melinda Stege Arsouze's 'reactiveness and availability.' She is US-qualified and her areas of expertise include IPOs, capital increases and convertible bonds. »
Chambers Global 2018

« Gide Loyrette Nouel A.A.R.P.I. demonstrates strength across the board of debt capital market financings, with 144A debt transactions by French issuers and Euro private placements areas of particular expertise. The team has a largely domestic workload but also excels in complex, cross-border matters, such as the work undertaken for Groupe FNAC on the issuance of €650m senior notes, which are governed by New York law, listed on the Irish Stock Exchange and admitted to trading on the Irish Stock Exchange’s Global Exchange Market. In another cross-border highlight, the team advised Veolia Environnement on the first issuance of a panda bond by a French issuer. Domestic highlights include advising Europcar Groupe on the issuance of 144A high-yield senior notes. Other clients include Société Générale, Gecina and BNP Paribas. Practice heads Arnaud Duhamel, Hubert Merveilleux du Vignaux and US-qualified Melinda Stege Arsouze are the key names. Laurent Vincent was promoted to counsel. »
Legal 500 EMEA 2018